Insider Buying: Creo Medical Group PLC (LON:CREO) Insider Buys £112,280 in Stock

Creo Medical Group PLC (LON:CREO) insider Kevin Crofton bought 701,750 shares of the business’s stock in a transaction on Friday, May 30th. The stock was bought at an average price of GBX 16 ($0.22) per share, for a total transaction of £112,280 ($152,161.54).

Creo Medical Group Stock Performance

Shares of CREO opened at GBX 15.80 ($0.21) on Thursday. Creo Medical Group PLC has a 12 month low of GBX 9.22 ($0.12) and a 12 month high of GBX 37.20 ($0.50). The firm has a market cap of £63.87 million, a PE ratio of -2.50 and a beta of 0.86. The company has a current ratio of 3.24, a quick ratio of 2.19 and a debt-to-equity ratio of 29.96. The stock has a fifty day moving average price of GBX 11.27 and a 200-day moving average price of GBX 14.79.

Creo Medical Group (LON:CREO) last posted its quarterly earnings results on Monday, May 19th. The company reported GBX (8) (($0.11)) earnings per share (EPS) for the quarter. Creo Medical Group had a negative return on equity of 41.79% and a negative net margin of 73.93%. Equities research analysts predict that Creo Medical Group PLC will post -10.0800005 earnings per share for the current fiscal year.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.